Clinical Trial Update: Prognostic Assessment of Contrast Echocardiography (PACE Study)

View source ↗

Summary

The PACE Study evaluated the prognostic value of contrast echocardiography in coronary artery disease. The trial has been terminated with Acusphere as the spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Acusphere contrast echocardiography agent

Snippet

Sponsor: Acusphere | Conditions: Coronary Artery Disease | Status: TERMINATED